ZA838080B - Magnesium trisilicate suitable for preparation of medicament absorbates - Google Patents

Magnesium trisilicate suitable for preparation of medicament absorbates

Info

Publication number
ZA838080B
ZA838080B ZA838080A ZA838080A ZA838080B ZA 838080 B ZA838080 B ZA 838080B ZA 838080 A ZA838080 A ZA 838080A ZA 838080 A ZA838080 A ZA 838080A ZA 838080 B ZA838080 B ZA 838080B
Authority
ZA
South Africa
Prior art keywords
magnesium trisilicate
medicament
absorbates
preparation
medicated product
Prior art date
Application number
ZA838080A
Other languages
English (en)
Inventor
David Peters
John Denick Jr
Anil K Talwar
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA838080B publication Critical patent/ZA838080B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Exhaust Gas Treatment By Means Of Catalyst (AREA)
  • External Artificial Organs (AREA)
  • Heat Treatment Of Steel (AREA)
  • Luminescent Compositions (AREA)
  • Golf Clubs (AREA)
  • Eye Examination Apparatus (AREA)
ZA838080A 1983-07-20 1983-10-28 Magnesium trisilicate suitable for preparation of medicament absorbates ZA838080B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/516,002 US4581232A (en) 1983-07-20 1983-07-20 Magnesium trisilicate suitable for preparation of medicament adsorbates

Publications (1)

Publication Number Publication Date
ZA838080B true ZA838080B (en) 1984-06-27

Family

ID=24053698

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA838080A ZA838080B (en) 1983-07-20 1983-10-28 Magnesium trisilicate suitable for preparation of medicament absorbates

Country Status (13)

Country Link
US (1) US4581232A (xx)
EP (1) EP0132472B1 (xx)
JP (1) JPS60112722A (xx)
AT (1) ATE44130T1 (xx)
AU (1) AU563740B2 (xx)
CA (1) CA1207232A (xx)
DE (1) DE3380090D1 (xx)
DK (1) DK159805C (xx)
ES (1) ES8607723A1 (xx)
FI (1) FI79785C (xx)
IE (1) IE56510B1 (xx)
NZ (1) NZ206101A (xx)
ZA (1) ZA838080B (xx)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8413191D0 (en) * 1984-05-23 1984-06-27 Beecham Group Plc Pharmaceutical composition
US4639368A (en) * 1984-08-23 1987-01-27 Farmacon Research Corporation Chewing gum containing a medicament and taste maskers
US4717565A (en) * 1986-03-27 1988-01-05 Warner-Lambert Company Process for the preparation of medicament adsorbates
US4711774A (en) * 1986-03-27 1987-12-08 Warner-Lambert Company Medicament adsorbates with complex magnesium aluminum silicate and their preparation
US4716033A (en) * 1986-03-27 1987-12-29 Warner-Lambert Company Medicament adsorbates with surfactant and their preparation
US4761274A (en) * 1986-03-27 1988-08-02 Warner-Lambert Company Medicament adsorbates of analgesics with complex magnesium aluminum silicate and their preparation
US4758424A (en) * 1986-03-27 1988-07-19 Warner-Lambert Company Medicament adsorbates of decongestants with complex magnesium aluminum silicate and their preparation
US4758425A (en) * 1986-03-27 1988-07-19 Warner-Lambert Company Medicament adsorbates of antiasthmatics with complex magnesium aluminum silicate and their preparation
US4820523A (en) * 1986-04-15 1989-04-11 Warner-Lambert Company Pharmaceutical composition
US5891801A (en) * 1987-07-17 1999-04-06 Calam And Associates, Inc. Palatable liquid-admininstered oral medicaments for relief of discomfort and flavoring combinations therefor
US5468482A (en) * 1987-07-17 1995-11-21 Calam & Associates, Inc. Palatable orally administered liquid medicaments for relief of discomfort and flavoring combinations therefor
JP2535707Y2 (ja) * 1991-04-05 1997-05-14 日本精工株式会社 リニアガイド装置のストッパ装置
US5302394A (en) * 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
WO1995003785A1 (en) * 1993-08-03 1995-02-09 Warner-Lambert Company Pleasant tasting effervescent cold/allergy medications
US5626878A (en) * 1995-01-10 1997-05-06 Warner Lambert Company Reduction of electrostatic forces between magnesium trisilicate adsorbates
US5766622A (en) * 1996-08-14 1998-06-16 The Procter & Gamble Company Inhibiting undesirable taste in oral compositions
US6384038B1 (en) * 1998-04-14 2002-05-07 Sepracor Inc. Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
US7067116B1 (en) 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
EA006777B1 (ru) * 2001-06-22 2006-04-28 Пфайзер Продактс Инк. Фармацевтические композиции адсорбатов аморфного лекарственного средства
EP1469832B2 (en) * 2002-02-01 2016-10-26 Bend Research, Inc. Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials
CA2532931A1 (en) * 2003-08-04 2005-02-10 Pfizer Products Inc. Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials
DK1566173T3 (da) * 2004-02-20 2006-12-27 Mattern Udo Farmaceutisk sammensætning til oral anvendelse og fremgangsmåde til fremstilling deraf
AU2005315291A1 (en) * 2004-12-13 2006-06-22 Mcneil-Ppc, Inc. Compositions and methods for stabilizing active pharmaceutical ingredients
US9125434B2 (en) 2007-10-11 2015-09-08 Philip Morris Products S.A. Smokeless tobacco product, smokeless tobacco product in the form of a sheet, extrudable tobacco composition, method for manufacturing a smokeless tobacco product, method for delivering super bioavailable nicotine contained in tobacco to a user, and packaged smokeless tobacco product sheet
CA2702222C (en) 2007-10-11 2016-08-30 Richard Fuisz Smokeless tobacco product
US20090098192A1 (en) * 2007-10-11 2009-04-16 Fuisz Richard C Extrudable and Extruded Compositions for Delivery of Bioactive Agents, Method of Making Same and Method of Using Same
US20090196907A1 (en) * 2008-01-31 2009-08-06 Bunick Frank J Edible film-strips for immediate release of active ingredients
CN102014883A (zh) * 2008-01-31 2011-04-13 麦克内尔-Ppc股份有限公司 具有调释型活性成分的可食用膜条片
CN110330023B (zh) * 2019-07-17 2020-10-13 云鹏医药集团有限公司 一种三硅酸镁的制备及干燥方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR799950A (fr) * 1935-03-27 1936-06-23 Mutosel Procédé de préparation de silicates complexes de bases organiques
US2881113A (en) * 1957-01-29 1959-04-07 Ortho Pharma Corp Therapeutically active compositions containing amphetamines
NL272604A (xx) * 1960-12-28
US3352752A (en) * 1963-07-25 1967-11-14 Tintex Corp Intestinal adsorbent compositions
US3337402A (en) * 1963-09-03 1967-08-22 Hoffmann La Roche Stable and palatable pharmaceutical composition
US3337403A (en) * 1963-09-05 1967-08-22 Hoffmann La Roche Stable and palatable pharmaceutical compositions
US3449266A (en) * 1964-05-25 1969-06-10 Drackett Co Stabilized solid granular perfume composition
US3272594A (en) * 1965-10-22 1966-09-13 Merck & Co Inc Preparation of magnesium trisilicate
US3567819A (en) * 1969-01-30 1971-03-02 Hoffmann La Roche Cold tablet
US3636200A (en) * 1969-06-09 1972-01-18 Hoffmann La Roche Pharmaceutical suspension
GB1236880A (en) * 1969-12-20 1971-06-23 Exp Drugs Company Antacid compositions
DE2217652A1 (de) * 1972-04-12 1973-10-18 Paolo Dr Sorbini Lyophilisierte arzneimittelprodukte und verfahren zu ihrer herstellung
DE2631947B2 (de) * 1976-07-15 1980-11-27 Bayer Ag, 5090 Leverkusen Verwendung von ätherischen ölen und Äthylalkohol
DE2845326C2 (de) * 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
IL58462A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a penicillin
JPS5594315A (en) * 1979-01-11 1980-07-17 Taiyo Yakuhin Kogyo Kk Antibacterial drug
JPS55129224A (en) * 1979-03-27 1980-10-06 Toyo Jozo Co Ltd Fine granules having improved taste
JPS5659707A (en) * 1979-10-19 1981-05-23 Toyo Jozo Co Ltd Lasting antibiotic pharmaceutical and its preparation

Also Published As

Publication number Publication date
IE56510B1 (en) 1991-08-28
DE3380090D1 (en) 1989-07-27
FI79785B (fi) 1989-11-30
ATE44130T1 (de) 1989-07-15
FI79785C (fi) 1990-03-12
EP0132472B1 (en) 1989-06-21
US4581232A (en) 1986-04-08
NZ206101A (en) 1985-09-13
DK553283A (da) 1985-01-21
EP0132472A1 (en) 1985-02-13
JPH0465811B2 (xx) 1992-10-21
DK553283D0 (da) 1983-12-01
IE832545L (en) 1985-01-20
ES526990A0 (es) 1986-06-01
AU563740B2 (en) 1987-07-23
CA1207232A (en) 1986-07-08
JPS60112722A (ja) 1985-06-19
DK159805C (da) 1991-05-06
AU2068983A (en) 1985-01-24
FI840615A (fi) 1985-01-21
ES8607723A1 (es) 1986-06-01
DK159805B (da) 1990-12-10
FI840615A0 (fi) 1984-02-15

Similar Documents

Publication Publication Date Title
ZA838080B (en) Magnesium trisilicate suitable for preparation of medicament absorbates
AU3502289A (en) Method for administering the drug deprenyl so as to minimize the danger of side effects
NZ315645A (en) Ipratropium bromide enantiomer with a prolonged duration of action
JPS55153715A (en) Prolonged granule of theophylline
AU557927B2 (en) Preparation of binderless 3a adsorbents use to dry h/c:s
CA2155200A1 (en) Use of topical anesthetics for the treatment of eosinophil-associated diseases
ES2077530A1 (es) Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
AU7921887A (en) Therapeutic agents
EP0239539A3 (en) Process for the preparation of medicament adsorbates
EP0153858A3 (en) The therapeutic use of prostaglandins
AU693833B2 (en) Products containing G-CSF and TNF binding protein
KR890003393A (ko) 복합 인산염 흡착제
WO1987000432A3 (en) Use of melatonin or related compounds for the treatment of psoriasis
EP0338415A3 (en) Use of sulphonylureas in the treatment of oedema
EP0147185A3 (en) Therapeutic use of cytidyl disphosphocholine to increase neuronal acetylcholine
DE3266072D1 (en) Method for the oral administration of substances in the form of liposomes, and relative pharmaceutical compositions
HUT50044A (en) Process for producing pharmaceutical composition comprising megestrol acetate as active ingredient
EP0428879A3 (en) Anhydrous crystal of 4-carbamoyl-1-beta-d-ribofuranosyl imidazolium-5-oleate
AU1494395A (en) The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
EP0359062A3 (en) Antibiotic ge 2270
EP0132772A3 (en) Fr-900216 substance obtainable by cultivating atcc 20577 for use as an active therapeutic substance and pharmaceutical antitumor composition comprising fr-900216 substance
EP0173145A3 (en) Reduction of the toxic effects caused by anthraquinone drugs
EP0127076A3 (en) Histargin, a microbiological process for its preparation, its use as a medicament, and the strain streptomyces roseoviridis having the ability to produce histargin
JPS55111427A (en) Separation of menthol isomer
EP0496474A3 (en) Saline derivates of glyceryl phosphoryl myoinositol having therapeutical activity, their preparation and pharmaceutical compositions containing them